Sio Gene Therapies Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$392.8M

148 transactions

Summary

Sio Gene Therapies Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $392.6MSales: —56 insiders

Date	Insider	Type	Value
2021-03-23	Cheruvu Pavan(Chief Executive Officer)	Buy	$248K
2021-12-08	Cheruvu Pavan(Chief Executive Officer)	F	$21K
2021-12-08	Nassif David W.(Chief Financial Officer)	F	$9K
2022-02-08	Nassif David W.(Interim CEO, CFO)	A	$0
2022-02-08	Meswani Parag V(Chief Commercial Officer)	A	$0
2021-12-08	Cheruvu Pavan(Chief Executive Officer)	D	$0
2021-12-08	Cheruvu Pavan(Chief Executive Officer)	A	$0
2021-12-08	Nassif David W.(Chief Financial Officer)	D	$0
2021-12-08	Nassif David W.(Chief Financial Officer)	A	$0
2021-04-15	Cheruvu Pavan(Chief Executive Officer)	A	$0
2021-04-15	Corcoran Gavin(Chief R&D Officer)	A	$0
2021-04-15	Nassif David W.(Chief Financial Officer)	A	$0
2021-04-15	Modig Berndt	A	$0
2021-04-15	Pande Atul	A	$0
2021-04-15	Sundaram Senthil Vel	A	$0
2021-04-15	Torti Frank	A	$0
2021-04-15	Vuori Kristiina MD	A	$0
2021-03-22	Nassif David W.(Chief Financial Officer)	D	$0
2021-03-22	Nassif David W.(Chief Financial Officer)	A	$0
2021-03-17	Cheruvu Pavan(Chief Executive Officer)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Sio Gene Therapies Inc. — Contributions, Lobbying & Contracts | Poliscope